Patents by Inventor Eugene DUAN

Eugene DUAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12485141
    Abstract: Embodiments of high molecular iodine concentration composition and pharmaceutical formulation are disclosed, which may be biostatic persistent, biocidal persistent, and have prolonged biocidal activities against microorganisms for hours after administration of the composition or pharmaceutical formulation. Articles comprising high molecular iodine concentration composition and pharmaceutical formulation, as well as preparation and use of same are also disclosed.
    Type: Grant
    Filed: August 13, 2021
    Date of Patent: December 2, 2025
    Assignee: I2PURE CORP.
    Inventors: Jack Kessler, Eugene Duan
  • Publication number: 20250000900
    Abstract: Provided are embodiments of high molecular iodine concentration composition and pharmaceutical formulation and quat-I2 composition comprising a) a quaternary amine (quat) composition and b) the high molecular iodine concentration composition, which may be biostatic persistent, biocidal persistent, and have prolonged biocidal activities against microorganisms for hours after administration of the composition or pharmaceutical formulation. Preparation and use of high molecular iodine concentration composition and pharmaceutical formulation and quat-I2 composition and pharmaceutical formulation are also disclosed. Articles comprising high molecular iodine concentration composition or pharmaceutical formulation or quat-I2 composition or pharmaceutical formulation, as well as preparation and use of same are also disclosed.
    Type: Application
    Filed: January 25, 2024
    Publication date: January 2, 2025
    Inventors: Jack KESSLER, Eugene DUAN
  • Publication number: 20220211751
    Abstract: Embodiments of high molecular iodine concentration composition and pharmaceutical formulation are disclosed, which may be biostatic persistent, biocidal persistent, and have prolonged biocidal activities against microorganisms for hours after administration of the composition or pharmaceutical formulation. Articles comprising high molecular iodine concentration composition and pharmaceutical formulation, as well as preparation and use of same are also disclosed.
    Type: Application
    Filed: August 13, 2021
    Publication date: July 7, 2022
    Inventors: Jack KESSLER, Eugene DUAN